X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse Wockhardt with MYLAN INC. - US - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

WOCKHARDT LTD. vs MYLAN (US) - Comparison Results

WOCKHARDT LTD.    Change

Wockhardt is one of the leading domestic pharmaceutical companies with strong presence in the lifestyle segment and a growing focus on biotechnology. While the company made a string of acquisitions in the past namely 'Esparma GmbH' in Germany, 'Pinew... More

MYLAN (US)
   Change

Mylan is one of the world’s leading generics and specialty pharmaceutical company. Its products span to customers in about 140 countries across the world. The company maintains one of the industry’s broadest and highest quality product portfolios, wh... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 WOCKHARDT LTD.   MYLAN
EQUITY SHARE DATA
    WOCKHARDT LTD.
Mar-17
MYLAN
Dec-14
WOCKHARDT LTD./
MYLAN
5-Yr Chart
Click to enlarge
High Rs1,1293,802-   
Low Rs6272,679-   
Sales per share (Unadj.) Rs363.11,301.5-  
Earnings per share (Unadj.) Rs-20.4156.8-  
Cash flow per share (Unadj.) Rs-7.0252.4-  
Dividends per share (Unadj.) Rs10.000-  
Dividend yield (eoy) %1.10-  
Book value per share (Unadj.) Rs301.8647.0-  
Shares outstanding (eoy) m110.55378.37-   
Bonus/Rights/Conversions ISOI-  
Price / Sales ratio x2.42.5 97.1%   
Avg P/E ratio x-42.920.7 -207.8%  
P/CF ratio (eoy) x-125.912.8 -980.4%  
Price / Book Value ratio x2.95.0 58.1%  
Dividend payout %-48.90-   
Avg Mkt Cap Rs m97,0631,226,120 7.9%   
No. of employees `0006.825.0 27.1%   
Total wages/salary Rs m9,6650-   
Avg. sales/employee Rs Th5,931.819,698.4 30.1%   
Avg. wages/employee Rs Th1,428.10-   
Avg. net profit/employee Rs Th-334.02,373.0 -14.1%   
INCOME DATA
Net Sales Rs m40,146492,459 8.2%  
Other income Rs m1,143-2,871 -39.8%   
Total revenues Rs m41,289489,588 8.4%   
Gross profit Rs m128122,477 0.1%  
Depreciation Rs m1,48936,169 4.1%   
Interest Rs m2,25321,242 10.6%   
Profit before tax Rs m-2,47262,195 -4.0%   
Minority Interest Rs m0-255 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-2112,615 -8.1%   
Profit after tax Rs m-2,26059,325 -3.8%  
Gross profit margin %0.324.9 1.3%  
Effective tax rate %8.54.2 203.1%   
Net profit margin %-5.612.0 -46.7%  
BALANCE SHEET DATA
Current assets Rs m46,160432,936 10.7%   
Current liabilities Rs m19,258338,470 5.7%   
Net working cap to sales %67.019.2 349.3%  
Current ratio x2.41.3 187.4%  
Inventory Days Days10178 129.0%  
Debtors Days Days94107 87.7%  
Net fixed assets Rs m40,165113,929 35.3%   
Share capital Rs m55317,415 3.2%   
"Free" reserves Rs m32,8140-   
Net worth Rs m33,367244,801 13.6%   
Long term debt Rs m31,903365,708 8.7%   
Total assets Rs m89,687986,034 9.1%  
Interest coverage x-0.13.9 -2.5%   
Debt to equity ratio x1.01.5 64.0%  
Sales to assets ratio x0.40.5 89.6%   
Return on assets %08.2 -0.1%  
Return on equity %-6.824.2 -28.0%  
Return on capital %-0.313.6 -2.5%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m6,9880-   
CASH FLOW
From Operations Rs m-2,69564,734 -4.2%  
From Investments Rs m-6,863-51,051 13.4%  
From Financial Activity Rs m12,545-17,057 -73.5%  
Net Cashflow Rs m3,010-3,374 -89.2%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for MYLAN (US) is United States Dollars. All data has been converted at 63.79 Rs / USD

Compare WOCKHARDT LTD. With: ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  

Compare WOCKHARDT LTD. With: FULFORD INDIA  CADILA HEALTHCARE  AJANTA PHARMA  ELDER PHARMA  ABBOTT INDIA  



Today's Market

Sensex Trades on a Volatile Note; Airtel, Idea Down by 5%(01:30 pm)

After opening the day in green share markets in India witnessed choppy trading activity and are presently trading above the dotted line.

Related Views On News

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Cipla: Strong Recovery Post GST (Quarterly Results Update - Detailed)

Nov 10, 2017

Cipla's India business recovers strongly this quarter post the GST issues in the first quarter of this fiscal.

Glenmark: Most Geographies Show Weak Growth (Quarterly Results Update - Detailed)

Nov 7, 2017

Poor show in the US, Latam and India hit profits during the quarter.

Lupin: US Markets Drags down Revenues and Net Profits (Quarterly Results Update - Detailed)

Nov 2, 2017

Domestic markets registers robust growth in the quarter

More Views on News

Most Popular

Mutual Funds Clearly Tell Us That There is a Bubble in the Stock Market(Vivek Kaul's Diary)

Jan 11, 2018

The maximum amount of money ever has come into equity mutual funds during the current financial year.

Did GST and Notebandi Help? Sherlock Holmes Finds Out...(The 5 Minute Wrapup)

Jan 13, 2018

Discussions with my cousin helped me understand the situation on Ground Zero - after the demonetization and GST upheaval. Here's what that means for listed companies...

Nirvana denied: Has Value Failed?(The Honest Truth)

Jan 13, 2018

Should investors choose growth over value this year?

'Smart Money' Enters Bitcoin. Will You?(Smart Contrarian)

Jan 17, 2018

As institutional money enters bitcoin, the gains over the last year could just be the tip of the iceberg.

Increasing Divergence Between Bond Yields and Earnings Yield(Chart Of The Day)

Jan 11, 2018

Over the past couple of months, bond yields have risen, but earning yields have fallen, increasing divergence.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

WOCKHARDT LTD. SHARE PRICE


Jan 24, 2018 02:01 PM

TRACK WOCKHARDT LTD.

  • Track your investment in WOCKHARDT LTD. with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON WOCKHARDT LTD.

WOCKHARDT LTD. 5-YR ANALYSIS

COMPARE WOCKHARDT LTD. WITH

MARKET STATS